Condition: Lung Cancer · Sponsor: NYU Langone Health
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
This description comes directly from the study's public registry record.
James J. Tsay, MD, MSc · 212-598-6351 · Jun-Chieh.Tsay@nyulangone.org
Rosemary M Schluger · 212-263-0255 · rosemary.schluger@nyulangone.org
Always discuss trial participation with your own doctor first.
| NYU Cancer Institute at New York University Medical Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00301119